SEOUL (Reuters) – South Korea’s major chipmakers Samsung Electronics and SK Hynix fell 1.9% and 3.9%, respectively, on Thursday, following losses in global chip stocks.
Wall Street’s semiconductor index lost more than $500 billion in stock market value on Wednesday in its worst session since 2020 after a report said the United States was considering tighter curbs on exports of advanced semiconductor technology to China.
Samsung announced it has invested in Generate: Biomedicines ("Generate") as part of its efforts to drive growth and innovation in the biopharmaceutical sector. The investment was made via the Samsung Life Science Fund, which was created jointly between Samsung Biologics,
Samsung Electronics Health and Medical Equipment Business and Samsung Medison participated in the 2024 Radiological Society of North America (RSNA) conference in Chicago, United States, from December 1st to 5th (local time) and unveiling an even more diverse product lineup. To
Samsung Electronics announced it plans to buy back a total of KRW 10 trillion in the Company’s shares to enhance shareholder value. The Company’s Board of Directors today authorized the share repurchase program that will be carried out in phases